株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポリメラーゼ連鎖反応 (PCR) 市場 - 成長、傾向、および予測(2019年 - 2024年)

Polymerase Chain Reaction Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 871438
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
ポリメラーゼ連鎖反応 (PCR) 市場 - 成長、傾向、および予測(2019年 - 2024年) Polymerase Chain Reaction Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 114 Pages
概要

ポリメラーゼ連鎖反応 (PCR)市場の成長の主な要因には、臨床診断における用途の拡大、個別化i医療および精密医療に対する需要の高まり、ならびに医薬品開発における技術の進歩および用途が挙げられます。

当レポートでは、ポリメラーゼ連鎖反応市場について調査しており、市場概況や成長要因・阻害要因、製品・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

  • 研究成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 臨床診断における用途の拡大
    • 個別化医療および精密医療に対する需要の高まり
    • 医薬品開発における技術の進歩と応用
  • 市場阻害要因
    • 機器の高コスト
    • 代替技術の出現
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界の競争

第5章 市場セグメント

  • 製品別
    • 装置
    • 試薬および消耗品
    • ソフトウェア
  • 用途別
    • 臨床診断
    • ライフサイエンス研究と産業用途
    • その他の用途
  • エンドユーザー別
    • 学術機関
    • 臨床診断検査室および病院
    • 製薬およびバイオテクノロジー産業
    • その他の
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • GE Healthcare
    • Merck KGaA
    • PerkinElmer Inc.
    • Promega Corporation
    • Siemens Healthcare
    • Thermo Fisher Scientific Inc.

第7章 市場機会および今後の動向

目次
Product Code: 64490

Market Overview

The major factors for the growth of the polymerase chain reaction market include the increasing application in clinical diagnostics, rising demand for personalized and precision medicine, and technological advancements and application in drug development.

Personalized medicine, which aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, has become popular over recent years. Personalized medicine holds the promise of providing better patient care and a high safety margin while also lowering the total healthcare costs. The rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine. In order to exploit these opportunities, novel technologies must be developed, which in turn results in the rapid expansion of the market studied. To gain a competitive advantage in the emerging field of personalized medicine, the biotechnology and pharmaceutical firms are exploring the grounds of genomic medicine and direct-to-consumer genetic testing. To develop these products, the industry is ramping up the R&D process in the areas of biotechnology where the polymerase chain reaction finds its major applications. Furthermore, the polymerase chain reaction is also gaining application in the molecular diagnosis of infectious and genetic diseases. Genetic tests that can detect genetic variations and predict how a person is likely to respond to certain drugs are becoming commercially available. To facilitate personalized medicine, it is crucial to develop precise and reproducible means of gaining molecular information about the underlying disease, which can be used to guide clinical decision-making, with PCR techniques being increasingly utilized in such methods. Therefore, increasing the focus on personalized medicine and patient-centered approach is driving the growth of the market studied.

Scope of the Report

As per the scope of this report, polymerase chain reaction (PCR) is a technique which is used to amplify target DNA and to generate thousands to millions of copies of a particular DNA segment. PCR techniques are used in clinical and research laboratories for a broad variety of applications which includes clinical diagnosis, criminal forensics, and biomedical research.

Key Market Trends

Clinical Diagnostics is the Segment by Application is expected to witness Fastest Growth over the Forecast Period

PCR based molecular diagnostic tests are increasingly being used to guide patient management, particularly in the fields of infectious disease, cancer, and congenital abnormalities. Globally the prevalence of genetic, infectious, and chronic diseases is on the rise and coupled with the increased availability of genetic and genomic information, it has led to the rapid incorporation of PCR techniques in clinical laboratories. The high specificity, sensitivity, and low sample requirement make PCR based molecular assay a go-to technique for the purpose of clinical diagnosis. PCR based molecular assays are becoming the primary mode of diagnosis for the detection of pathogens in case of a rapid disease outbreak, such as the recent Zika and Ebola virus outbreaks. This trend is primarily due to low or non-availability of rapid or specific diagnostic tests for such diseases. In the field of oncology, PCR techniques are routinely used for tumor profiling and prognosis. In the field of infectious disease for detection of bacterial infections, such as tuberculosis by Mycobacterium tuberculosis and for viral infections, such as HIV infection. Pertaining to broad applications of PCR in the field of clinical diagnostics, the market segment is likely to register high growth during the forecast period.

North America is Expected to Dominate the Market

The increasing prevalence of genetic and chronic disorders, such as cancer, aging population, growing demand for precision and personalized medicine, and favorable government initiatives are the primary factors driving the growth of the market. The growth can also be attributed to the presence of sophisticated diagnostic laboratories and the high acceptance rate of novel assay technologies. There is a growing trend of genetic engineering and genomic research in academia and biotechnology industries of the United States. Increasing genomic research is primarily fueled by the high demand for targeted and precision medicine, for the management of chronic disorders, as well as due to the need for understanding the genetic and molecular basis of disease. In recent years, several government initiatives have been launched, which are supplementing the growth of the PCR market. For example, in 2015, the Precision Medicine Initiative was introduced to revolutionize the treatment of chronic diseases, including cancer. Initiatives like these are presenting a favorable environment for the pharmaceutical and biotechnology firms to develop and market gene-based diagnostics and therapeutics, which in turn fuel the growth of PCR technologies, due to their wide applications in drug discovery, toxicity, and efficacy studies, as well as in general life science research.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of the few major market players. Some of the market players are Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation, Siemens Healthcare, and Thermo Fisher Scientific Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Application in Clinical Diagnostics
    • 4.2.2 Rising Demand for Personalized and Precision Medicine
    • 4.2.3 Technological Advancements and Application in Drug Development
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments
    • 4.3.2 Emergence of Alternative Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Instruments
      • 5.1.1.1 Standard PCR Systems
      • 5.1.1.2 Digital PCR Systems
      • 5.1.1.3 Real-Time PCR Systems
    • 5.1.2 Reagents and Consumables
    • 5.1.3 Software
  • 5.2 By Application
    • 5.2.1 Clinical Diagnostics
    • 5.2.2 Life Science Research and Industrial Applications
    • 5.2.3 Other Applications
  • 5.3 By End User
    • 5.3.1 Academic Institutes
    • 5.3.2 Clinical Diagnostics Labs and Hospitals
    • 5.3.3 Pharmaceutical and Biotechnology Industries
    • 5.3.4 Other
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Agilent Technologies, Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 bioMerieux SA
    • 6.1.5 Bio-Rad Laboratories Inc.
    • 6.1.6 GE Healthcare
    • 6.1.7 Merck KGaA
    • 6.1.8 PerkinElmer Inc.
    • 6.1.9 Promega Corporation
    • 6.1.10 Siemens Healthcare
    • 6.1.11 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top